A multicenter, randomized, double-blind, placebo-controlled, parallel-design, exploratory study of orally administered ERB-041 [prinaberel] in subjects with active interstitial cystitis
Phase of Trial: Phase II
Latest Information Update: 29 Mar 2007
At a glance
- Drugs Prinaberel (Primary)
- Indications Interstitial cystitis
- Focus Therapeutic Use
- 29 Mar 2007 New trial record.